tiprankstipranks
AFYREN (FR:ALAFY)
:ALAFY
Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) AI Stock Analysis

1 Followers

Top Page

FR:ALAFY

AFYREN

(ALAFY)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
€2.00
▼(-29.82% Downside)
Action:ReiteratedDate:04/10/26
The score is held down primarily by weak financial performance—shrinking revenue, large and widening losses, and persistent negative operating/free cash flow—despite a relatively stronger low-debt balance sheet. Technical indicators also reflect a clear downtrend (below key moving averages with negative MACD), while valuation is constrained by negative earnings and no indicated dividend yield.
Positive Factors
Low Leverage / Strong Equity Base
A materially lower debt load and a sizeable equity base give AFYREN structural financial flexibility. Low leverage reduces insolvency risk during multi-year scaling, supports the ability to raise capital on reasonable terms, and buys time to commercialize plants and convert contracts into recurring cash flow.
Negative Factors
Shrinking Revenue and Widening Losses
Sustained declines in top-line and materially larger net losses weaken the company's ability to attain scale economies and fund industrial projects internally. Persistent revenue contraction undermines commercial traction and raises long-term questions about demand capture and the pathway to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Equity Base
A materially lower debt load and a sizeable equity base give AFYREN structural financial flexibility. Low leverage reduces insolvency risk during multi-year scaling, supports the ability to raise capital on reasonable terms, and buys time to commercialize plants and convert contracts into recurring cash flow.
Read all positive factors

AFYREN (ALAFY) vs. iShares MSCI France ETF (EWQ)

AFYREN Business Overview & Revenue Model

Company Description
AFYREN SAS, a sustainable chemical company, produces biomolecules derived from the recycling of non-food biomass, primarily used in human and animal nutrition, flavors and fragrances, life sciences, materials sciences, and lubricants sectors. It o...
How the Company Makes Money
AFYREN makes money primarily by selling bio-based organic acids and derived products produced through its proprietary fermentation process. Its core revenue stream is product sales (B2B), where customers purchase specific acids (and potentially bl...

AFYREN Financial Statement Overview

Summary
Operating performance is weak: revenue has declined materially in 2024–2025 and profitability is deeply negative, including a large gross loss in 2025 and widening net losses. Cash flow remains consistently negative, indicating ongoing cash burn, partly offset by a comparatively stronger, low-debt balance sheet that provides some financial flexibility.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.27M2.86M3.38M3.46M3.04M
Gross Profit-5.49M-174.00K645.00K1.06M1.47M
EBITDA-6.81M-8.81M-8.59M-4.71M-2.78M
Net Income-14.37M-9.75M-9.59M-9.20M-3.61M
Balance Sheet
Total Assets67.14M58.56M70.43M84.82M93.15M
Cash, Cash Equivalents and Short-Term Investments35.16M33.65M49.66M62.40M67.36M
Total Debt2.42M3.31M4.79M8.54M8.95M
Total Liabilities4.19M5.86M8.63M13.84M15.29M
Stockholders Equity62.10M52.70M61.80M70.98M77.86M
Cash Flow
Free Cash Flow-5.29M-5.84M-5.60M-3.83M-3.06M
Operating Cash Flow-5.09M-5.62M-5.04M-3.30M-2.71M
Investing Cash Flow-15.25M-9.11M-3.08M-362.00K-436.00K
Financing Cash Flow21.96M-1.28M-4.66M-1.14M60.77M

AFYREN Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.85
Price Trends
50DMA
2.82
Negative
100DMA
2.82
Negative
200DMA
2.61
Negative
Market Momentum
MACD
-0.12
Positive
RSI
21.20
Positive
STOCH
7.69
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAFY, the sentiment is Negative. The current price of 2.85 is above the 20-day moving average (MA) of 2.67, above the 50-day MA of 2.82, and above the 200-day MA of 2.61, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 21.20 is Positive, neither overbought nor oversold. The STOCH value of 7.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALAFY.

AFYREN Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
€105.83B26.2813.87%2.06%-0.43%6.33%
67
Neutral
€1.58B18.411.35%4.50%16.15%
62
Neutral
€4.69B62.512.27%7.05%-4.99%-82.38%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
€123.89M-1.33-19.12%90.91%-22.05%
55
Neutral
€74.13M22.8813.64%1.28%6.27%-0.96%
43
Neutral
€96.35M-5.27-22.98%-20.58%-41.43%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:ALAFY
AFYREN
2.48
0.82
49.40%
FR:AI
Air Liquide
183.08
1.12
0.61%
FR:AKE
Arkema
62.00
-0.98
-1.55%
FR:ALCRB
Carbios SA
7.33
-0.53
-6.74%
FR:ALBKK
Baikowski SA
20.20
3.05
17.80%
FR:CBE
Robertet SA Cert.d'Invest. Em.87
692.00
-18.14
-2.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 10, 2026